NCT01654250 - NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

NWP09

Methylphenidate, variable dose, daily dosing, 1 week duration

DRUG

Placebo

Trial Locations (9)

Florida Clinical Research Center, LLC, Bradenton

Woodland Community Church (Laboratory School), Bradenton

Clinical Study Centers, LLC, Little Rock

Bayou City Research, Ltd., Houston

Westex Clinical Investigations, Lubbock

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

UC Irvine Child Development Center, Irvine

Laboratory School, Huntington Beach

UC Irvine - Hewitt Hall, Irvine